Pfizer (PFE) - Get Report CEO Jeff Kindler has hinted that the world's biggest drugmaker is open to a large-scale acquisition. "The real goal is to grow revenues," he told the Financial Times recently. "We are open to opportunities and constantly looking at those which are big, small and in between."
This quote has been the recent rage for biotech investors of late, who are speculating that Pfizer, with its AAA credit rating and more than $25 billion in cash, is planning to make a large-scale acquisition soon.
Here is a list of some of the companies that Pfizer might be considering. Remember, Pfizer is looking to totally revamp its pipeline with this acquisition.
To read more,
Stockpickr is a wholly owned subsidiary of TheStreet.com.